University of British Columbia researchers are conducting a national study to measure the effect on patient access and health outcomes of proposed changes to Canada’s medical cannabis regulations, which would end the practice of homegrown marijuana and move to a national market of licensed producers. The Cannabis Access Regulations Study (CANARY) will follow more than 300 patients over the next year.
Dr. Lynda Balneaves
Principal Investigator, Associate Professor in UBC’s School of Nursing
“This study is the first of its kind to capture patients’ perspectives of a competitive national market for medical cannabis through licensed producers.”
PhD student, Interdisciplinary Studies Graduate Program
“It’s simply not known whether the changes [to Canada’s medical cannabis regulations] would be beneficial or harmful. The CANARY study will help us understand the impact on patients and provide us early indication of the pros and cons of the program.”
More information about the study and a link to the survey can be found at http://www.canarystudy.ca